Automated oxygen administration
DeviceIn the control group, usual oxygen administration and titration is planned
Other names: Usual oxygen administration
NCT Number: NCT03122210
During acute coronary syndrome, the American College of Cardiology and the American Heart Association recommend oxygen delivery to patients with less than 90% oxygen saturation. Oxygen therapy in these patients for a duration of at least 6 hours, but also stipulates that it is reasonable to administer oxygen to all acute coronary syndrome patients during the first six hours following the presentation. Hyperoxia also has well-established risks.
Our research hypotheses are:
(I) that current practices tend to use high oxygen flows resulting in high SpO2 levels during acute coronary syndrome.
(II) there is a high rate of desaturation in patients with acute coronary syndrome and an automatic adaptation of oxygen flows may reduce this frequency.
(III) that excessive oxygenation targets have no advantage. Our hypothesis is that maintaining a SpO2 of 90 to 94% is at least equivalent when compared to higher saturation objectives (SpO2 of 94 to 100%) with regard to the occurrence of complications in the patient in acute coronary syndrome . We will use two SpO2 targets with the FreeO2 system, 92 and 97%.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hypoxemia is a common problem encountered during acute coronary syndrome. During acute coronary syndrome, the American College of Cardiology and the American Heart Association recommend oxygen delivery to patients with less than 90% oxygen saturation. Oxygen therapy in these patients for a duration of at least 6 hours , but also stipulates that it is reasonable to administer oxygen to all acute coronary syndrome patients during the first six hours Following the presentation. However, the studies underlying these guidelines are few and far between, most of them having been done more than forty years ago.
Hyperoxia also has well-established risks.
Our research hypotheses are:
(I) that current practices tend to use high oxygen flows resulting in high SpO2 levels during acute coronary syndrome.
(II) there is a high rate of desaturation in patients with acute coronary syndrome and an automatic adaptation of oxygen flows may reduce this frequency. This will be our primary endpoint and will be tested with the use of the automated oxygen delivery system.
(III) that excessive oxygenation targets have no advantage. Our hypothesis is that maintaining a SpO2 of 90 to 94% is at least equivalent when compared to higher saturation objectives (SpO2 of 94 to 100%) with regard to the occurrence of complications in the patient in acute coronary syndrome . We will use two SpO2 targets with the FreeO2 system, 92 and 97%.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the control group, usual oxygen administration and titration is planned
Other names: Usual oxygen administration
Time frame: 24 hours
Time frame: 24 hours
Time frame: 24 hours
Laval University
Other
Acronym: FreeO2 SCA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05123885
Cardiovascular Diseases, Heart Diseases
Amiens, France
View Trial DetailsNCT04096079
Cardiovascular Diseases, Heart Arrest
View Trial DetailsNCT00196274
Cardiovascular Diseases, Heart Diseases
Munich, Germany
View Trial DetailsNCT00196261
Cardiovascular Diseases, Heart Diseases
Munich, Germany
View Trial Details